van Groeningen CJ - Search Results

1

Lack of effectiveness of combined 5-fluorouracil and leucovorin in patients with 5-fluorouracil-resistant advanced colorectal cancer.

van Groeningen CJ, Peters GJ, Pinedo HM. van Groeningen CJ, et al. Eur J Cancer Clin Oncol. 1989 Jan;25(1):45-9. doi: 10.1016/0277-5379(89)90049-7. Eur J Cancer Clin Oncol. 1989. PMID: 2784100

2

Clinical relevance of biochemical modulation of 5-fluorouracil.

Peters GJ, van Groeningen CJ. Peters GJ, et al. Among authors: van groeningen cj. Ann Oncol. 1991 Jul;2(7):469-80. doi: 10.1093/oxfordjournals.annonc.a057994. Ann Oncol. 1991. PMID: 1911453 Free article. Review.

3

In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients.

Peters GJ, Schwartsmann G, Nadal JC, Laurensse EJ, van Groeningen CJ, van der Vijgh WJ, Pinedo HM. Peters GJ, et al. Among authors: van groeningen cj, van der vijgh wj. Cancer Res. 1990 Aug 1;50(15):4644-9. Cancer Res. 1990. PMID: 2164443

4

Schedule-dependency of in vivo modulation of 5-fluorouracil by leucovorin and uridine in murine colon carcinoma.

Nadal JC, van Groeningen CJ, Pinedo HM, Peters GJ. Nadal JC, et al. Among authors: van groeningen cj. Invest New Drugs. 1989 Jul;7(2-3):163-72. doi: 10.1007/BF00170853. Invest New Drugs. 1989. PMID: 2793368

5

Reversal of 5-fluorouracil-induced myelosuppression by prolonged administration of high-dose uridine.

van Groeningen CJ, Peters GJ, Leyva A, Laurensse E, Pinedo HM. van Groeningen CJ, et al. J Natl Cancer Inst. 1989 Jan 18;81(2):157-62. doi: 10.1093/jnci/81.2.157. J Natl Cancer Inst. 1989. PMID: 2909757

6

Diurnal variation in the therapeutic efficacy of 5-fluorouracil against murine colon cancer.

Peters GJ, Van Dijk J, Nadal JC, Van Groeningen CJ, Lankelma J, Pinedo HM. Peters GJ, et al. Among authors: van groeningen cj, van dijk j. In Vivo. 1987 Mar-Apr;1(2):113-7. In Vivo. 1987. PMID: 2979771

7

In vivo potentiation of 5-fluorouracil by leucovorin in murine colon carcinoma.

Nadal JC, Van Groeningen CJ, Pinedo HM, Peters GJ. Nadal JC, et al. Among authors: van groeningen cj. Biomed Pharmacother. 1988;42(6):387-93. Biomed Pharmacother. 1988. PMID: 3064823 Review.

8

Pharmacokinetics of 5-fluorouracil assessed with a sensitive mass spectrometric method in patients on a dose escalation schedule.

van Groeningen CJ, Pinedo HM, Heddes J, Kok RM, de Jong AP, Wattel E, Peters GJ, Lankelma J. van Groeningen CJ, et al. Cancer Res. 1988 Dec 1;48(23):6956-61. Cancer Res. 1988. PMID: 3180104

9

In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil.

Peters GJ, van Dijk J, Laurensse E, van Groeningen CJ, Lankelma J, Leyva A, Nadal JC, Pinedo HM. Peters GJ, et al. Among authors: van groeningen cj, van dijk j. Br J Cancer. 1988 Mar;57(3):259-65. doi: 10.1038/bjc.1988.56. Br J Cancer. 1988. PMID: 3355763 Free PMC article.

10

Current chemotherapeutic possibilities in the treatment of colorectal cancer.

van Triest B, van Groeningen CJ, Pinedo HM. van Triest B, et al. Among authors: van groeningen cj. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1193-7. doi: 10.1016/0959-8049(95)00161-b. Eur J Cancer. 1995. PMID: 7577020 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters